Cargando…
COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia
Infection with SARS-CoV-2 causes critical disease in approximately 5% of affected patients, particularly the elderly, hypertensive, obese and immunocompromised. Patients with haematological cancer, including chronic lymphocytic leukaemia (CLL), are particularly at risk of complications. Very rarely,...
Autores principales: | Alves Barbosa, Orivaldo, Guimarães Andrade, Talita, de Almeida Sousa, Maria Danielly, Correia, José Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350966/ https://www.ncbi.nlm.nih.gov/pubmed/32665936 http://dx.doi.org/10.12890/2020_001763 |
Ejemplares similares
-
Pseudohypoxemia From Leukocyte Larceny in a Patient With Chronic Myelogenous Leukemia
por: Mirzai, Saeid, et al.
Publicado: (2022) -
Overcoming the problem of pseudohypoxemia in myeloproliferative disorders: Another trick in the bag
por: Prasad, K. N., et al.
Publicado: (2012) -
COVID-19 in a patient with chronic lymphocytic leukaemia
por: Jin, Xiang-Hong, et al.
Publicado: (2020) -
Whipple’s Disease as the First Manifestation of Chronic Lymphocytic Leukaemia
por: Guiomar, Verónica, et al.
Publicado: (2019) -
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)